Evidence map›Paper›PMID 32525899›Full record

ArticlePloS one2020

Notch3 signaling promotes tumor cell adhesion and progression in a murine epithelial ovarian cancer model.

Jessica C Price, Elham Azizi, L A Naiche, Jenny G Parvani, Priyanka Shukla, Seoyeon Kim, Jill K Slack-Davis, Dana Pe'er, Jan K Kitajewski

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jessica C PriceIntegrated Program in Cellular Molecular and Biomedical Studies, Columbia University, New York, NY, United States of America.
Elham AziziProgram for Computational and Systems Biology, Parker Institute for Cancer Immunotherapy, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.
L A NaicheDepartment of Physiology and Biophysics, University of Illinois Chicago, Chicago, IL, United States of America.ORCID 0000-0002-5031-4804
Jenny G ParvaniDepartment of Physiology and Biophysics, University of Illinois Chicago, Chicago, IL, United States of America.
Priyanka ShuklaDepartment of Physiology and Biophysics, University of Illinois Chicago, Chicago, IL, United States of America.
Seoyeon KimDepartment of Physiology and Biophysics, University of Illinois Chicago, Chicago, IL, United States of America.
Jill K Slack-DavisDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States of America.
Dana Pe'erProgram for Computational and Systems Biology, Parker Institute for Cancer Immunotherapy, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.
Jan K KitajewskiDepartment of Physiology and Biophysics, University of Illinois Chicago, Chicago, IL, United States of America.
University of Illinois Chicago · USMemorial Sloan Kettering Cancer Center · USColumbia University · USUniversity of Virginia · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesisU54CA209975 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LESLIE, CHRISTINA S, RUDENSKY, ALEXANDER Y · 2016 to 2021
$11.8M
Notch in Angiogenesis and Vascular BiologyR01HL112626 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Jan K. Kitajewski · 2012 to 2026
$6.3M
Single cell mapping of developmental trajectories underlying health and diseaseDP1HD084071 · NICHD · SLOAN-KETTERING INST CAN RESEARCH · PI PE'ER, DANA · 2014 to 2018
$4.2M
Integrative Cancer Genomics: Drivers, Pathways and DrugsR01CA164729 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PE'ER, DANA · 2012 to 2016
$1.9M
Signaling in the ovarian cancer metastatic microenvironmentR01CA142783 · NCI · UNIVERSITY OF VIRGINIA · PI SLACK-DAVIS, JILL · 2010 to 2015
$1.7M
Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironmentR00CA230195 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI AZIZI, ELHAM · 2020 to 2022
$652k
Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironmentK99CA230195 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI AZIZI, ELHAM · 2018 to 2019
$269k
Evaluating Notch Signaling as a Therapeutic Target in Ovarian CancerF31CA192891 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRICE, JESSICA · 2014 to 2018
$224k
NCI NIH HHS F31 CA192891NCI NIH HHS K99 CA230195NCI NIH HHS P30 CA008748NCI NIH HHS R00 CA230195NCI NIH HHS R01 CA142783NCI NIH HHS R01 CA164729NCI NIH HHS U54 CA209975NHLBI NIH HHS R01 HL112626NICHD NIH HHS DP1 HD084071
6 · The paper itself

Abstract

High grade serous ovarian cancer (HGSC) is the most common and deadly type of ovarian cancer, largely due to difficulties in early diagnosis and rapid metastasis throughout the peritoneal cavity. Previous studies have shown that expression of Notch3 correlates with worse prognosis and increased tumorigenic cell behaviors in HGSC. We investigated the mechanistic role of Notch3 in a model of metastatic ovarian cancer using the murine ovarian surface epithelial cell line, ID8 IP2. Notch3 was activated in ID8 IP2 cells via expression of the Notch3 intracellular domain (Notch3IC). Notch3IC ID8 IP2 cells injected intraperitoneally caused accelerated ascites and reduced survival compared to control ID8 IP2, particularly in early stages of disease. We interrogated downstream targets of Notch3IC in ID8 IP2 cells by RNA sequencing and found significant induction of genes that encode adhesion and extracellular matrix proteins. Notch3IC ID8 IP2 showed increased expression of ITGA1 mRNA and cell-surface protein. Notch3IC-mediated increase of ITGA1 was also seen in two human ovarian cancer cells. Notch3IC ID8 IP2 cells showed increased adhesion to collagens I and IV in vitro. We propose that Notch3 activation in ovarian cancer cells causes increased adherence to collagen-rich peritoneal surfaces. Thus, the correlation between increased Notch3 signaling and poor prognosis may be influenced by increased metastasis of HGSC via increased adherence of disseminating cells to new metastatic sites in the peritoneum.

Indexed as

AnimalsCarcinogenesisCarcinoma, Ovarian EpithelialCell AdhesionCell Line, TumorCystadenocarcinoma, SerousDisease ProgressionExtracellular Matrix ProteinsFemaleHumansMiceMice, NudeOvarian NeoplasmsPeritoneal NeoplasmsReceptor, Notch3Extracellular Matrix ProteinsNotch3 protein, mouseReceptor, Notch3

Identifiers

PMID32525899
PMCPMC7289394
OpenAlexW3035241525

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.